外用项痹舒膏联合红光照射治疗神经根型颈椎病的临床观察

发布时间：2018-06-27 07:30

本文选题：项痹舒膏 + 红光照射　；参考：《黑龙江中医药大学》2017年硕士论文

【摘要】：目的:研究CSR病患治疗前后的临床症状改善情况以及生活质量等,探索外用项痹舒膏联合红光照射对神经根型颈椎病的治疗效果,从而系统全面的对该治疗方法临床应用价值进行分析。方法:抽选2016年全年骨伤四科收治的病患进行临床研究,病患经多项检查确诊为CSR,在其中再次选择满足纳入标准的病患(60例)进行分组,每组都为30例,组别命名是对照组和治疗组,治疗组行外用项痹舒膏联合红光照射治疗,而对照组则单纯应用红光照射进行治疗,在治疗两周之后观察病患病情改善情况,并开展统计学研究。结果:外用项痹舒膏联合红光照射的治疗组有9例患者症状体征基本消失,属治愈,而12例病患对于疗效评价为满意,即为显效,6例病患疗效评价是尚可,即有效,有3例病患治疗效果评定是无效,总的有效率是90%,临床治愈率达30%;而以单纯应用红光照射的病患(对照组)治疗痊愈的只有3例,7例病患疗效评价是显效,12例是尚可,视为有效,无效者一共有8例,总的有效率(73.3%)低于治疗组,治愈率也较低(10%)。结论:1,本次试验表明以上两组治疗经过均可明显缓解CSR病人的临床表现及预后。2,外用项痹舒膏联合红光照射的治疗效果要较单独使用红光照射效果好。3,此次治疗的方法便捷,简单实用,安全性高等优点,为CSR的诊疗提供了一种安全有效的治疗方法,值得临床推广。
[Abstract]:Objective: to study the improvement of clinical symptoms and quality of life (QOL) in CSR patients before and after treatment. The clinical application value of this treatment method was analyzed systematically and comprehensively. Methods: a clinical study was conducted among the patients admitted to four departments of bone injury in 2016. The patients were confirmed as CSR by multiple examinations. Among them, 60 patients (60 patients) who met the inclusion criteria were selected and divided into groups of 30 patients in each group. The treatment group was named as control group and treatment group. The treatment group was treated with external application of Shengbishu ointment combined with red light irradiation, while the control group was treated only with red light irradiation. After two weeks of treatment, the improvement of the patient's condition was observed and the statistical study was carried out. Results: in the treatment group, the symptoms and signs of 9 patients were basically disappeared and cured, while 12 patients were satisfied with the evaluation of curative effect. Three patients were evaluated as ineffective, the total effective rate was 90, the clinical cure rate was 30%, and only 3 patients (control group) treated with red light alone were cured. The total effective rate (73.3%) was lower than that of the treatment group (73.3%), and the cure rate was lower (10%). Conclusion: 1, this experiment shows that the two groups can significantly alleviate the clinical manifestations and prognosis of CSR patients after treatment. The therapeutic effect of external application of Shengbishu plaster combined with red light irradiation is better than that of red light irradiation alone. This treatment method is convenient. It provides a safe and effective method for the diagnosis and treatment of CSR and is worth popularizing.
【学位授予单位】：黑龙江中医药大学
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：R681.55

【参考文献】